BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 17901250)

  • 1. Long-term outcome following hematopoietic stem-cell transplantation in Wiskott-Aldrich syndrome: collaborative study of the European Society for Immunodeficiencies and European Group for Blood and Marrow Transplantation.
    Ozsahin H; Cavazzana-Calvo M; Notarangelo LD; Schulz A; Thrasher AJ; Mazzolari E; Slatter MA; Le Deist F; Blanche S; Veys P; Fasth A; Bredius R; Sedlacek P; Wulffraat N; Ortega J; Heilmann C; O'Meara A; Wachowiak J; Kalwak K; Matthes-Martin S; Gungor T; Ikinciogullari A; Landais P; Cant AJ; Friedrich W; Fischer A
    Blood; 2008 Jan; 111(1):439-45. PubMed ID: 17901250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome: an EBMT Inborn Errors Working Party analysis.
    Albert MH; Slatter MA; Gennery AR; Güngör T; Bakunina K; Markovitch B; Hazelaar S; Sirait T; Courteille V; Aiuti A; Aleinikova OV; Balashov D; Bernardo ME; Bodova I; Bruno B; Cavazzana M; Chiesa R; Fischer A; Hauck F; Ifversen M; Kałwak K; Klein C; Kulagin A; Kupesiz A; Kuskonmaz B; Lindemans CA; Locatelli F; Lum SH; Maschan A; Meisel R; Moshous D; Porta F; Sauer MG; Sedlacek P; Schulz A; Suarez F; Vallée TC; Winiarski JH; Zecca M; Neven B; Veys P; Lankester AC
    Blood; 2022 Mar; 139(13):2066-2079. PubMed ID: 35100336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980-2009: an international collaborative study.
    Moratto D; Giliani S; Bonfim C; Mazzolari E; Fischer A; Ochs HD; Cant AJ; Thrasher AJ; Cowan MJ; Albert MH; Small T; Pai SY; Haddad E; Lisa A; Hambleton S; Slatter M; Cavazzana-Calvo M; Mahlaoui N; Picard C; Torgerson TR; Burroughs L; Koliski A; Neto JZ; Porta F; Qasim W; Veys P; Kavanau K; Hönig M; Schulz A; Friedrich W; Notarangelo LD
    Blood; 2011 Aug; 118(6):1675-84. PubMed ID: 21659547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful Reduced Intensity Allogeneic Transplant With Full Donor Chimerism and Good Quality of Life in Adolescent Patient With Wiskott-Aldrich Syndrome.
    Ali S; Gacsadi A; McDougall E; Armstrong C; Krueger J; Schechter T; Ali M
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e267-e269. PubMed ID: 28538502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes after Allogeneic Transplant in Patients with Wiskott-Aldrich Syndrome.
    Ngwube A; Hanson IC; Orange J; Rider NL; Seeborg F; Shearer W; Noroski L; Nicholas S; Forbes L; Leung K; Sasa G; Naik S; Hegde M; Omer B; Ahmed N; Allen C; Gottschalk S; Wu MF; Liu H; Brenner M; Heslop H; Krance R; Martinez C
    Biol Blood Marrow Transplant; 2018 Mar; 24(3):537-541. PubMed ID: 29196075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.
    Burroughs LM; Petrovic A; Brazauskas R; Liu X; Griffith LM; Ochs HD; Bleesing JJ; Edwards S; Dvorak CC; Chaudhury S; Prockop SE; Quinones R; Goldman FD; Quigg TC; Chandrakasan S; Smith AR; Parikh S; Dávila Saldaña BJ; Thakar MS; Phelan R; Shenoy S; Forbes LR; Martinez C; Chellapandian D; Shereck E; Miller HK; Kapoor N; Barnum JL; Chong H; Shyr DC; Chen K; Abu-Arja R; Shah AJ; Weinacht KG; Moore TB; Joshi A; DeSantes KB; Gillio AP; Cuvelier GDE; Keller MD; Rozmus J; Torgerson T; Pulsipher MA; Haddad E; Sullivan KE; Logan BR; Kohn DB; Puck JM; Notarangelo LD; Pai SY; Rawlings DJ; Cowan MJ
    Blood; 2020 Jun; 135(23):2094-2105. PubMed ID: 32268350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A risk factor analysis of outcomes after unrelated cord blood transplantation for children with Wiskott-Aldrich syndrome.
    Shekhovtsova Z; Bonfim C; Ruggeri A; Nichele S; Page K; AlSeraihy A; Barriga F; de Toledo Codina JS; Veys P; Boelens JJ; Mellgren K; Bittencourt H; O'Brien T; Shaw PJ; Chybicka A; Volt F; Giannotti F; Gluckman E; Kurtzberg J; Gennery AR; Rocha V;
    Haematologica; 2017 Jun; 102(6):1112-1119. PubMed ID: 28255019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report.
    Pury S; López Orozco M; Pichichero G; Sasia LV; Morell D; Álvarez MS; Basquiera AL; Mas ME; Salvucci K
    Arch Argent Pediatr; 2024 Feb; 122(1):e202310061. PubMed ID: 37471507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematopoietic stem cell transplantation for patients with Wiskott-Aldrich syndrome].
    Wietstruck P MA; Zúñiga C P; Talesnik G E; Méndez R C; Barriga C F
    Rev Med Chil; 2007 Jul; 135(7):917-23. PubMed ID: 17914550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results and long-term outcome in 39 patients with Wiskott-Aldrich syndrome transplanted from HLA-matched and -mismatched donors.
    Friedrich W; Schütz C; Schulz A; Benninghoff U; Hönig M
    Immunol Res; 2009; 44(1-3):18-24. PubMed ID: 18846321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome.
    Hacein-Bey Abina S; Gaspar HB; Blondeau J; Caccavelli L; Charrier S; Buckland K; Picard C; Six E; Himoudi N; Gilmour K; McNicol AM; Hara H; Xu-Bayford J; Rivat C; Touzot F; Mavilio F; Lim A; Treluyer JM; Héritier S; Lefrère F; Magalon J; Pengue-Koyi I; Honnet G; Blanche S; Sherman EA; Male F; Berry C; Malani N; Bushman FD; Fischer A; Thrasher AJ; Galy A; Cavazzana M
    JAMA; 2015 Apr; 313(15):1550-63. PubMed ID: 25898053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic efficacy of hematopoietic stem cell transplantation for Wiskott-Aldrich syndrome in 60 children].
    Zhou C; Luo CY; Wang JM; Luo CJ; Qin X; Huang XH; Chen J
    Zhonghua Er Ke Za Zhi; 2023 Apr; 61(4):351-356. PubMed ID: 37011982
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-term outcome and chimerism in patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation: a retrospective nationwide survey.
    Iguchi A; Cho Y; Yabe H; Kato S; Kato K; Hara J; Koh K; Takita J; Ishihara T; Inoue M; Imai K; Nakayama H; Hashii Y; Morimoto A; Atsuta Y; Morio T;
    Int J Hematol; 2019 Sep; 110(3):364-369. PubMed ID: 31187438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hematopoietic Stem Cell Transplantation for X-Linked Thrombocytopenia With Mutations in the WAS gene.
    Oshima K; Imai K; Albert MH; Bittner TC; Strauss G; Filipovich AH; Morio T; Kapoor N; Dalal J; Schultz KR; Casper JT; Notarangelo LD; Ochs HD; Nonoyama S
    J Clin Immunol; 2015 Jan; 35(1):15-21. PubMed ID: 25388447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation.
    Pai SY; DeMartiis D; Forino C; Cavagnini S; Lanfranchi A; Giliani S; Moratto D; Mazza C; Porta F; Imberti L; Notarangelo LD; Mazzolari E
    Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B-cell reconstitution after lentiviral vector-mediated gene therapy in patients with Wiskott-Aldrich syndrome.
    Castiello MC; Scaramuzza S; Pala F; Ferrua F; Uva P; Brigida I; Sereni L; van der Burg M; Ottaviano G; Albert MH; Grazia Roncarolo M; Naldini L; Aiuti A; Villa A; Bosticardo M
    J Allergy Clin Immunol; 2015 Sep; 136(3):692-702.e2. PubMed ID: 25792466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful Reduced Intensity Conditioning Alternate Donor Stem Cell Transplant for Wiskott-Aldrich Syndrome.
    Thakkar D; Katewa S; Rastogi N; Kohli S; Nivargi S; Yadav SP
    J Pediatr Hematol Oncol; 2017 Nov; 39(8):e493-e496. PubMed ID: 28859032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical features of autoimmunity in 53 patients with Wiskott-Aldrich syndrome in China: a single-center study.
    Chen N; Zhang ZY; Liu DW; Liu W; Tang XM; Zhao XD
    Eur J Pediatr; 2015 Oct; 174(10):1311-8. PubMed ID: 25877044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.